Jim Fong

Corporate Officer/Principal en CTI BIOPHARMA CORP. .

62 años

Health Technology

Consumer Services

Cargos activos de Jim Fong

Empresas	Cargo	Inicio	Fin
CTI BIOPHARMA CORP.	Corporate Officer/Principal	01/01/2008	-
CTI BIOPHARMA CORP.	Director de Operaciones	01/01/2017	-

Empresas	Cargo	Inicio	Fin
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Ventas & Marketing	-	-

University of California, Los Angeles

Undergraduate Degree

Internacional

Estados Unidos

Operativa

Chief Operating Officer	1
Corporate Officer/Principal	1
Undergraduate Degree	1

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	2
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.	Health Technology
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology

Empresas privadas

Health Technology